Global Access Strategy Lead, Cardiovascular

at  Amgen

JOIN AMGEN’S MISSION OF SERVING PATIENTS

At Amgen, if you feel like you’re part of something bigger, it’s because you are. Our shared mission—to serve patients living with serious illnesses—drives all that we do.
Since 1980, we’ve helped pioneer the world of biotech in our fight against the world’s toughest diseases. With our focus on four therapeutic areas –Oncology, Inflammation, General Medicine, and Rare Disease– we reach millions of patients each year. As a member of the Amgen team, you’ll help make a lasting impact on the lives of patients as we research, manufacture, and deliver innovative medicines to help people live longer, fuller happier lives.
Our award-winning culture is collaborative, innovative, and science based. If you have a passion for challenges and the opportunities that lay within them, you’ll thrive as part of the Amgen team. Join us and transform the lives of patients while transforming your career.

BASIC QUALIFICATIONS:

Doctorate degree and 4 years of market access and/or payer experience
Or
Master’s degree and 8 years of market access and/or payer experience
Or
Bachelor’s degree and 9 years of market access and/or payer experience

PREFERRED QUALIFICATIONS:

• Experience working in the cardiovascular space
• International launch experience
• Strong understanding of the payer environment in the US and major ex-US countries, including coverage and reimbursement, pricing, health technology assessment, and healthcare policy.
• Ability to conduct situation analysis of external pricing and reimbursement environment and synthesize relevant information to develop strategic plans and formulate price policy recommendations
• Ability to develop and test value messages and value evidence with payers in order to determine the most compelling way in which to demonstrate and communicate product value to payers
• Ability to translate complex situation and pricing analyses to effectively communicate impact to Amgen business
• Ability to manage in a highly fluid, interactive, matrixed environment and build strong, successful business partnerships with affiliate, regional and global colleagues
• Strong analytical skills and ability to think and plan strategically, identify strategic options and trade-offs and bring structure to vaguely defined problems
• Excellent oral/written communications skills and interpersonal skills

Let’s do this. Let’s change the world! In the context of a rapidly evolving payer environment, Amgen’s emphasis on geographic expansion, and a commitment to demonstrate product value, Amgen requires an increasingly sophisticated reimbursement and pricing capability to support market access strategies (an important source for competitive advantage).
The Global Integrated Access Strategy team, within the Global Value Access (GV&A) function, is a team committed to excellence in this capability in order to position Amgen for continued success. This global team is responsible for strategic planning of value and access for all Amgen molecules in development, beginning in Phase I-II and extending throughout commercialization across the Amgen portfolio. This work also includes lifecycle planning and access support for our inline products. Additionally, the team is responsible for global strategic pricing, including recommendations for global price policies and launch sequence, and delivering on above-brand initiatives to build our strategic capabilities.
In this vital role the Director will serve as the Global Access Strategy Lead (ASL) for Olpasiran, a molecule being developed for the treatment of elevated Lp(a) in patients at risk of cardiovascular events, and will represent payers’ needs and perspectives on the multi-disciplinary Product Team (PT).
They will also lead and coordinate the cross-functional efforts within Global Value Access (GV&A) in order to support the access planning process, including the situation analysis, creation of access strategies, identification of critical success factors, development of pricing guidance and maintenance of price policy. The individual will also collaborate with the PT to reflect payer-value drivers in the assessment and design of the Olpasiran LCM pivotal trials and key evidence generation projects. This opportunity will involve significant interaction with top 10 markets and sub-regions to lead access launch readiness and execution of the global access strategy. The individual will be responsible for pricing and access assumptions in global revenue forecasts for select products. The Director must also oversee and conduct relevant payer/pricing market research and Value Evidence Generation (with HEOR) and integrate clinical, market and payer information to develop and communicate the access plan.
Each ASL will work collaboratively across functions to ensure a comprehensive view of their assigned products and create and maintain strong working relationships with key stakeholders. These individuals include global colleagues in marketing, development, HEOR, regulatory, operations, advocacy, and government affairs as well as key markets and regional VA colleagues within the US, Europe, Canada, Japan/Asia-Pacific/Australia and other markets.
In addition to product-specific responsibilities, each member of the team also participates in cross-portfolio projects each year. These projects either serve to advance the department’s knowledge of and readiness for the global access environment, support specific market or product assessments, or attempt to shape access policy development.